科幂仪器完成数千万元B轮融资，加速合成设备国产替代与连续流技术突破

Core Viewpoint - The recent B-round financing of Anhui Kemi Instrument Co., Ltd. (Kemi Instrument) signifies recognition of its innovative capabilities and market potential in the synthetic equipment sector, with funds allocated for R&D, equipment updates, and global business expansion [1]. Group 1: Company Overview - Kemi Instrument has developed a comprehensive range of intermittent and continuous flow synthetic equipment, serving major universities and leading enterprises in strategic emerging industries such as new materials, new energy, and biomedicine [4]. - The company operates a nearly 10,000 square meter R&D and manufacturing base and is recognized as a national high-tech enterprise, holding an A2-level production qualification license for special equipment in China [4]. - Kemi Instrument's products are exported to Europe, America, Australia, and the Middle East, having served over 20,000 domestic and international research and enterprise clients, contributing to over 4,000 R&D applications and more than 1,000 SCI (一区) publications [4]. Group 2: Financing and Advisory - The B-round financing, amounting to several tens of millions of RMB, was led by Chuangjing Capital, with Changhai Capital acting as the exclusive financial advisor [1]. - Changhai Capital specializes in the healthcare sector, providing tailored financing strategies and services, and has experience in high-value financing for companies in medical devices, IVD, and healthcare services [2][3].